跳至主要内容
临床试验/IRCT20220809055645N4
IRCT20220809055645N4招募中3 期

Comparison of efficacy and safety of Heparin and Enoxaparin versus control group in patients undergoing primary percutaneous intervention: An open labelled randomized clinical trial

Rasht University of Medical Sciences0 个研究点目标入组 171 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
171

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Myocardial infarction with ST segment elevation

排除标准

  • Having coagulopathy
  • Having no consent to participate in the study and follow-up courses
  • Having underlying bleeding disorders, mechanical valve history
  • Presence of other indications for receiving anticoagulants
  • Absolute prohibition of receiving anticoagulants (such as active bleeding at the time of visit, drug sensitivity)
  • GFR lower than 30
  • liver failure

研究者

发起方
Rasht University of Medical Sciences

相似试验